These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33108127)

  • 1. Editorial: Testosterone replacement therapy: present use and future directions.
    Rotker KL
    Curr Opin Endocrinol Diabetes Obes; 2020 Dec; 27(6):396. PubMed ID: 33108127
    [No Abstract]   [Full Text] [Related]  

  • 2. Testosterone replacement therapy: current trends and future directions.
    Nieschlag E; Behre HM; Bouchard P; Corrales JJ; Jones TH; Stalla GK; Webb SM; Wu FC
    Hum Reprod Update; 2004; 10(5):409-19. PubMed ID: 15297434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone supplementation does not worsen lower urinary tract symptoms.
    Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
    J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of testosterone replacement therapy in men with hypogonadism: A meta-analysis study of placebo-controlled trials.
    Guo C; Gu W; Liu M; Peng BO; Yao X; Yang B; Zheng J
    Exp Ther Med; 2016 Mar; 11(3):853-863. PubMed ID: 26998003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone delivery systems for women: present status and future promise.
    Casson PR; Carson SA; Buster JE
    Semin Reprod Endocrinol; 1998; 16(2):153-9. PubMed ID: 9711681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between Testosterone-Replacement Therapy and Lower Urinary Tract Symptoms: A Systematic Review.
    Kathrins M; Doersch K; Nimeh T; Canto A; Niederberger C; Seftel A
    Urology; 2016 Feb; 88():22-32. PubMed ID: 26616095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with transdermal testosterone replacement therapy for hypogonadal men.
    Parker S; Armitage M
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):57-62. PubMed ID: 10341856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk of Male Infertility Due to Testosterone Replacement Therapy for Late-Onset Hypogonadism (LOH)].
    Sukegawa G; Tsuji Y
    Hinyokika Kiyo; 2020 Nov; 66(11):407-409. PubMed ID: 33271659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone treatment to mimic hormone physiology in androgen replacement therapy. A view on testosterone gel and other preparations available.
    Fabbri A; Giannetta E; Lenzi A; Isidori AM
    Expert Opin Biol Ther; 2007 Jul; 7(7):1093-106. PubMed ID: 17665996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefit and risk of testosterone replacement therapy in older men: effects on lipid metabolism.
    Volpato S; Vigna GB; Fellin R
    Acta Biomed; 2010; 81 Suppl 1():95-9. PubMed ID: 20518198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
    Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
    J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of testosterone replacement therapy in adolescents with Klinefelter syndrome.
    Mehta A; Clearman T; Paduch DA
    J Urol; 2014 May; 191(5 Suppl):1527-31. PubMed ID: 24679877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of physiotherapy in addition to testosterone replacement therapy on the efficiency of the motor system in men with hypogonadism.
    Bacevičienė R; Valonytė L; Ceponis J
    Medicina (Kaunas); 2013; 49(2):71-7. PubMed ID: 23888342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy.
    Hsieh TC; Pastuszak AW; Hwang K; Lipshultz LI
    J Urol; 2013 Feb; 189(2):647-50. PubMed ID: 23260550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compounded Testosterone Troches TO OPTIMIZE HEALTH AND THE TESTOSTERONE CONTROVERSY.
    Guth MA
    Int J Pharm Compd; 2015; 19(3):195-203. PubMed ID: 26714360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
    Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
    Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of testosterone therapy in hypogonadal patients and its controversial adverse impact on the cardiovascular system.
    Kharaba ZJ; Buabeid MA; Alfoteih YA
    Crit Rev Toxicol; 2020 Jul; 50(6):491-512. PubMed ID: 32689855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone replacement therapy.
    Velázquez E; Bellabarba Arata G
    Arch Androl; 1998; 41(2):79-90. PubMed ID: 9730436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future testosterone delivery systems for treatment of the hypogonadal male.
    Pfeil E; Dobs AS
    Expert Opin Drug Deliv; 2008 Apr; 5(4):471-81. PubMed ID: 18426387
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.